Comparison of Prostaglandin F2α, Bimatoprost (Prostamide), and Butaprost (EP2 Agonist) on Cyr61 and Connective Tissue Growth Factor Gene Expression
Open Access
- 1 July 2003
- journal article
- research article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 278 (29) , 27267-27277
- https://doi.org/10.1074/jbc.m301009200
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Phosphorylation of Glycogen Synthase Kinase-3 and Stimulation of T-cell Factor Signaling following Activation of EP2 and EP4 Prostanoid Receptors by Prostaglandin E2Journal of Biological Chemistry, 2002
- Peroxisome Proliferator-activated Receptor γ Inhibits Transforming Growth Factor β-induced Connective Tissue Growth Factor Expression in Human Aortic Smooth Muscle Cells by Interfering with Smad3Journal of Biological Chemistry, 2001
- Effects of AGN 192024, a new ocular hypotensive agent, on aqueous dynamicsAmerican Journal of Ophthalmology, 2001
- Factor VIIa and Thrombin Induce the Expression of Cyr61 and Connective Tissue Growth Factor, Extracellular Matrix Signaling Proteins That Could Act as Possible Downstream Mediators in Factor VIIa·Tissue Factor-induced Signal TransductionJournal of Biological Chemistry, 2000
- Functional Characterization of the Ocular Prostaglandin F2α (PGF2α) ReceptorPublished by Elsevier ,1997
- Cloning of human prostanoid receptorsTrends in Pharmacological Sciences, 1995
- Molecular evolution of receptors for eicosanoidsFEBS Letters, 1995
- Molecular Characterization and Ocular Hypotensive Properties of the Prostanoid EP2ReceptorJournal of Ocular Pharmacology and Therapeutics, 1995
- Connective tissue growth factor: a cysteine-rich mitogen secreted by human vascular endothelial cells is related to the SRC-induced immediate early gene product CEF-10.The Journal of cell biology, 1991
- Prostaglandin and thromboxane biosynthesisPharmacology & Therapeutics, 1991